CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Grifols Completes Clinical Portion of Phase 3 Trial of Prolastin-C in Emphysema

Phase 3Prolastin-CNeutral
AI Analysis

Summary

Grifols has completed the clinical portion of a Phase 3 trial of Prolastin-C for emphysema treatment. No efficacy data or timeline for results were disclosed in this announcement.

Clinical Trial Data

Phase

Phase 3

Importance:5/10
Sentiment:
0.00
Phase 3Clinical TrialProlastin-CEmphysema
Related Companies

Read the original article

Published by yahoo_finance on August 10, 2026 1:12 PM

Read Original